Role of Sex in the Therapeutic Targeting of p53 Circuitry
Open Access
- 8 July 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
Abstract
Sex profoundly affects cancer incidence and susceptibility to therapy, with sex hormones highly contributing to this disparity. Various studies and omics data suggest a relationship between sex and the oncosuppressor p53 circuitry, including its regulators MDM2 and MDM4. Association of this network with genetic variation underlies sex-related altered cancer risk, age of onset, and cancer sensitivity to therapy. Moreover, sex-related factors, mainly estrogenic hormones, can affect the levels and/or function of the p53 network both in hormone-dependent and independent cancer. Despite this evidence, preclinical and clinical studies aimed to evaluate p53 targeted therapy rarely consider sex and related factors. This review summarizes the studies reporting the relationship between sex and the p53 circuitry, including its associated regulators, MDM2 and MDM4, with particular emphasis on estrogenic hormones. Moreover, we reviewed the evaluation of sex/hormone in preclinical studies and clinical trials employing p53-target therapies, and discuss how patients' sex and hormonal status could impact these therapeutic approaches.Funding Information
- Associazione Italiana per la Ricerca sul Cancro
This publication has 112 references indexed in Scilit:
- Association of a Genetic Variation in a miR-191 Binding Site in MDM4 with Risk of Esophageal Squamous Cell CarcinomaPLOS ONE, 2013
- Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer RiskPLoS Genetics, 2013
- An integrated map of genetic variation from 1,092 human genomesNature, 2012
- Estrogen receptor prevents p53-dependent apoptosis in breast cancerProceedings of the National Academy of Sciences of the United States of America, 2012
- The MDM2 Promoter SNP285C/309G Haplotype Diminishes Sp1 Transcription Factor Binding and Reduces Risk for Breast and Ovarian Cancer in CaucasiansCancer Cell, 2011
- A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferationBreast Cancer Research, 2011
- Tumor Repressive Functions of Estrogen Receptor β in SW480 Colon Cancer CellsCancer Research, 2009
- Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogeneProceedings of the National Academy of Sciences of the United States of America, 2009
- Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?Breast Cancer Research, 2009
- Estrogen and progesterone induce persistent increases in p53-dependent apoptosis and suppress mammary tumors in BALB/c-Trp53+/-miceBreast Cancer Research, 2008